Invictus MD Strategies Corp


By |

Driven by a team of fast-moving entrepreneurs, management leaders, and industry-recognized horticulturists, Invictus MD is powering the future of the legal cannabis industry.

Since going public in 2014, Invictus MD has grown through early acquisitions and rapid business development to what it is today. With our focus completely on regulated cannabis production, we now manage and operate several licensed facilities across Canada with access to over 250 acres of cultivation space. All our properties revolve around our core initiative to build out a dominant production profile that can support a wide variety of high-quality strains. With the proper care and attention to detail, we are dedicated to continuously growing with this new industry in an honest, transparent and socially-responsible way.

Optimized from the ground up

With presence in Alberta and Ontario, all of our facilities are designed and maintained for optimal plant growth. Site-specific conditions such as climate, humidity, and fresh water supply is leveraged for their passive benefits, resulting in a highly-efficient cultivation system with low operational costs.

Our platform includes ancillary products such as plant nutrients and fertilizers, giving us direct control over every element of the growing process. Having this visibility is a crucial component to our ability to produce a safe and organic product, time and time again.

Data-driven production

Our cultivation methodology combines proven agricultural techniques with the advantages of automation and technology. Conditions that are critical for healthy plant growth—temperature, humidity, carbon dioxide levels—are constantly monitored and optimized by an autonomous system. This mitigates risk of human error while ensuring that each facilities remain lean in operation.

From clone to bud, every equipment and system design has been engineered to ensure consistent growth, high quality yields, and competitive cost per gram.


An experienced platform of growers

The quality of our product is achieved and constantly obsessed over by a team of dedicated cultivators, biochemists, and agricultural engineers. Every variable of the growing process has been calculated and designed in order to ensure the cleanest, healthiest grow.

We support our growers with state-of-the-art production and processing facilities that not only provide the necessary square footage for cultivating cannabis, but also equips them with the right tools, technology, and industry knowledge to help them focus on the goal: delivering a high-quality product that you can trust.

Acreage Pharms Ltd.

100% Ownership

Acreage Pharms a Licensed Producer under the Access to Cannabis for Medical Purposes Regulations (“ACMPR”) has constructed a 6,800 square foot purpose built production facility with an expansion of a 27,000 square feet purpose built concrete and steel facility within the 60,000 square foot secured perimeter that sits on 150 acres of land. This large land package makes Acreage Pharms very well positioned to become one of the largest producers of cannabis in the Canadian sector.

Alberta has low cost of production as a result of low energy and water costs. The property is friendly to building as many square feet as required based on the significant demand.

  • Secured permitter: 60,277 sq ft
  • Phase I: 6,800 sq ft production facility – Complete
  • Phase II: 27,000 sq ft expansion
  • Phase III: 76,750 sq ft expansion on existing property – subject to permitting

AB Laboratories Inc.

33.3% Ownership

Occupying a cultivation space of 16,000 sq ft, AB Labs is a Licensed Producer under the Access to Cannabis for Medical Purposes Regulations (”ACMPR”). It plays a critical role in our strong production profile. The building houses multiple grow rooms for cultivation, trimming, and drying in a controlled and regulated environment.

AB Ventures Inc.

33.3% Ownership

AB Ventures Inc.’s, a newly incorporated company formed to develop a second licensed expansion facility through it’s common ownership with AB Labs, 100-acre acquisition closed in May 2017, and once licensed under the ACMPR, will be used for future cannabis cultivation. Once approval has been received by ACMPR construction will begin of the initial cultivation facilities, with plans to construct additional production facilities on the new land as demand increases. With licensing in place as expected, production at AB Ventures is anticipated to start as early as December 2017.

Future Harvest

82.5% Ownership

Manufactured by growers, Future Harvest is a hydroponiccs and fertilizer manufacturer and supplier. Having developed their industry-leading products over 20 years, Future Harvest is how we ensure that everything that goes into our soil and plants is from a clean and dependable source.

Future Harvest products which are specifically designed for the market. Each proprietary formula has been developed and tested to ensure that every plant received nutrients.

Download our investor deck

There’s much more information on our team, production properties, and our projected growth curve with the timing of a recreational roll-out. It also includes:

  • Breakdown of facilities
  • Capitalization structure
  • Future Harvest performance
  • Company road map from going public
  • Combined Cannabis Production Profile
  • Management & Board of Directors

Download Now

Invictus MD Strategies Corp


Invictus MD Strategies Corp. (TSXV: GENE; OTC: IVITF) is focused on two main verticals within the burgeoning Canadian cannabis sector: Licensed Producers under the ACMPR, including its wholly owned subsidiary Acreage Pharms Ltd., as well as its investment in the fully licensed facility AB Laboratories Inc.; and Fertilizer and Nutrients through Future Harvest Development Ltd.

Contact Information

Address: 15047 Marine Drive
Address 2: Suite 300
State: BC
City / Town: White Rock
Country: CAN
Postal Code: V4B 1C5

Issuer Information

Exchange: CDX
CEO: Daniel Kriznic
Issuer Type: CS - Common Stock
Sector/Industry: Healthcare
NAICS: Medicinal and Botanical Manufacturing(325411)
$ 0.80 $ -0.06 (-6.98%)
Last Price 0.80 Change $ -0.06 Change % -6.98 Tick N/A
Bid 0.79 Bid Size 2,000.00 Ask 0.89 Ask Size 24,500.00
Open 0.87 High 0.89 Low 0.77 Prev Close 0.86
Last Trade Volume 400,619 52 Wk Hi 2.79 52 Wk Low 0.77
Market Cap 89.7 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 112,176,712.00 EPS (TTM) N/A PE Ratio N/A Exchange TSXV